Expert Video - How do doctors treat lung cancer with KRAS mutations?
Medical oncologist and lung cancer expert Dr. Naomi Fujioka provides an overview of how lung cancers with KRAS mutations are treated. She discusses the use of KRAS inhibitors sotorasib and adagrasib that target the KRAS G12C mutation. She also discusses ongoing clinical trials researching how to combine KRAS inhibitors with other treatments, using KRAS inhibitors earlier in lung cancer treatment, and research on therapies targeting KRAS G12D.
Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about lung cancer which will help other patients, caregivers and families.
Animation - Understanding NSCLC Treatment Options When You Have a KRAS Mutation
Slide Show - Understanding NSCLC Treatment Options When You Have a KRAS Mutation
1.
What is a gene mutation and how does it relate to lung cancer?
2.
How do doctors test for genetic mutations in lung cancer and why is it important?
3.
What is a KRAS mutation in non-small cell lung cancer (NSCLC)?
4.
How do doctors treat lung cancer with KRAS mutations?
5.
How did you find out you had KRAS-positive lung cancer?
6.
What was the comprehensive biomarker testing experience like?
7.
What has your treatment experience been for your KRAS-positive lung cancer?
8.
What advice do you have for newly diagnosed lung cancer patients about biomarker testing?
9.
How did you find out you had KRAS-positive lung cancer?
10.
How has your KRAS mutation affected the treatment options available to you?
